Now in press in #Pain, from Dr. Amol Patwardhan's lab at UT Southwestern Medical Center:
The conotoxin Contulakin-G reverses hypersensitivity... : PAIN journals.lww.com/pain/fulltex...
The conotoxin Contulakin-G reverses hypersensitivity... : PAIN journals.lww.com/pain/fulltex...
The conotoxin Contulakin-G reverses hypersensitivity... : PAIN
conotoxin, Contulakin-G (CGX), has been demonstrated to be an antinociceptive agent in postsurgical and neuropathic pain states via a neurotensin receptor 2 (NTSR2)-mediated pathway. However, the effi...
journals.lww.com
January 10, 2025 at 8:41 PM
Now in press in #Pain, from Dr. Amol Patwardhan's lab at UT Southwestern Medical Center:
The conotoxin Contulakin-G reverses hypersensitivity... : PAIN journals.lww.com/pain/fulltex...
The conotoxin Contulakin-G reverses hypersensitivity... : PAIN journals.lww.com/pain/fulltex...
#Contulakin-G (CGX), a conotoxin targeting the neurotensin receptor 2 (NTSR2), shows promise for cancer-induced bone pain, acting via #Cav2.3 channels #PainResearch #Neuroscience #Conotoxins #NTSR2
journals.lww.com/pain/fulltex...
journals.lww.com/pain/fulltex...
February 24, 2025 at 8:31 PM
#Contulakin-G (CGX), a conotoxin targeting the neurotensin receptor 2 (NTSR2), shows promise for cancer-induced bone pain, acting via #Cav2.3 channels #PainResearch #Neuroscience #Conotoxins #NTSR2
journals.lww.com/pain/fulltex...
journals.lww.com/pain/fulltex...
Now in #PAIN: “The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance” by Martin et al. bit.ly/40gcesr
From the lab of Dr. Amol Patwardhan @utswtxid.bsky.social
From the lab of Dr. Amol Patwardhan @utswtxid.bsky.social
The conotoxin Contulakin-G reverses hypersensitivity... : PAIN
conotoxin, Contulakin-G (CGX), has been demonstrated to be an antinociceptive agent in postsurgical and neuropathic pain states via a neurotensin receptor 2 (NTSR2)-mediated pathway. However, the effi...
bit.ly
February 14, 2025 at 3:23 PM
Now in #PAIN: “The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance” by Martin et al. bit.ly/40gcesr
From the lab of Dr. Amol Patwardhan @utswtxid.bsky.social
From the lab of Dr. Amol Patwardhan @utswtxid.bsky.social
Now in #PAIN: “The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance” by Martin et al. bit.ly/40gcesr
February 14, 2025 at 6:00 PM
Now in #PAIN: “The conotoxin Contulakin-G reverses hypersensitivity observed in rodent models of cancer-induced bone pain without inducing tolerance or motor disturbance” by Martin et al. bit.ly/40gcesr
Contulakin G (CAS 229180-41-0) | GMP Supplier & Manufacturer
Contulakin G (CAS 229180-41-0) is a glycosylated neuropeptide that functions as a neurotensin receptor agonist with antinociceptive properties. It is widely used in preclinical studies exploring pain modulation, receptor pharmacology,…
Contulakin G (CAS 229180-41-0) is a glycosylated neuropeptide that functions as a neurotensin receptor agonist with antinociceptive properties. It is widely used in preclinical studies exploring pain modulation, receptor pharmacology,…
Contulakin G (CAS 229180-41-0) | GMP Supplier & Manufacturer
Contulakin G (CAS 229180-41-0) is a glycosylated neuropeptide that functions as a neurotensin receptor agonist with antinociceptive properties. It is widely used in preclinical studies exploring pain modulation, receptor pharmacology, and neuropeptide signaling. Manufactured under GMP conditions, Contulakin G is intended strictly for laboratory research use.(Please contact our staff to place an order or learn about product wholesale prices, specifications, uses and lists)
arizona-mall.com
August 28, 2025 at 12:03 PM
Contulakin G (CAS 229180-41-0) | GMP Supplier & Manufacturer
Contulakin G (CAS 229180-41-0) is a glycosylated neuropeptide that functions as a neurotensin receptor agonist with antinociceptive properties. It is widely used in preclinical studies exploring pain modulation, receptor pharmacology,…
Contulakin G (CAS 229180-41-0) is a glycosylated neuropeptide that functions as a neurotensin receptor agonist with antinociceptive properties. It is widely used in preclinical studies exploring pain modulation, receptor pharmacology,…